TENET HEALTHCARE CORP(THC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #510 of 2,879 stocksTOP 25%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
THC Stock Analysis & AI Quality Score
AI stock analysis and institutional research for TENET HEALTHCARE CORP (THC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores THC at 66.6/100 on a 32-signal composite quality model, placing it at rank #510 of 2,879 stocks — the top 25% of the AI-ranked universe. THC scores in the top quartile across revenue scale (93.1), balance sheet strength (84.3), institutional flow (75.5). Areas of concern include earnings quality (27.7) and revenue growth (37.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), TENET HEALTHCARE CORP reports quarterly revenue of $5.4B, net income of $906.0M, free cash flow of $1.5B. Top institutional holders of THC by reported 13-F value include BlackRock,, FMR, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. THC trades on the NYSE exchange and files with the SEC under CIK 70318. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate THC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TENET HEALTHCARE CORP directly from SEC EDGAR.
Revenue
Q1 2026
$5.4B
Net Income
Q1 2026
$906.0M
Free Cash Flow
Q1 2026
$1.5B
ROIC
Q1 2026
7.2%
D/E Ratio
Q1 2026
2.74
Get alerted when THC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for TENET HEALTHCARE CORP including:
Top Institutional Holders of THC
BlackRock, Inc.
$1.6B8,704,644 shFMR LLC
$1.5B7,776,579 shVANGUARD PORTFOLIO MANAGEMENT LLC
$814.6M4,316,887 shVANGUARD CAPITAL MANAGEMENT LLC
$738.1M3,911,408 shBoston Partners
$723.7M3,834,961 shSTATE STREET CORP
$512.5M2,715,925 shWELLINGTON MANAGEMENT GROUP LLP
$442.5M2,344,919 shLONE PINE CAPITAL LLC
$426.2M2,258,717 shGEODE CAPITAL MANAGEMENT, LLC
$364.4M1,930,447 shInvesco Ltd.
$337.2M1,787,016 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $1.6B | 8,704,644 |
| FMR LLC | $1.5B | 7,776,579 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $814.6M | 4,316,887 |
| VANGUARD CAPITAL MANAGEMENT LLC | $738.1M | 3,911,408 |
| Boston Partners | $723.7M | 3,834,961 |
| STATE STREET CORP | $512.5M | 2,715,925 |
| WELLINGTON MANAGEMENT GROUP LLP | $442.5M | 2,344,919 |
| LONE PINE CAPITAL LLC | $426.2M | 2,258,717 |
| GEODE CAPITAL MANAGEMENT, LLC | $364.4M | 1,930,447 |
| Invesco Ltd. | $337.2M | 1,787,016 |
More Healthcare Companies
View all Healthcare →Put THC on your watchlist
Track score changes the day TENET HEALTHCARE CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is THC a good stock to buy?
13F Pro's AI-powered analysis of TENET HEALTHCARE CORP (THC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for THC are available on the THC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own THC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling THC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of TENET HEALTHCARE CORP's investment landscape.